396 related articles for article (PubMed ID: 21801835)
1. FXR and PXR: potential therapeutic targets in cholestasis.
Jonker JW; Liddle C; Downes M
J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):147-58. PubMed ID: 21801835
[TBL] [Abstract][Full Text] [Related]
2. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
[TBL] [Abstract][Full Text] [Related]
4. [Role of PXR and CAR in cholestasis].
Suh JI
Korean J Hepatol; 2006 Mar; 12(1):5-15. PubMed ID: 16565602
[TBL] [Abstract][Full Text] [Related]
5. Nuclear receptors as drug targets in cholestatic liver diseases.
Halilbasic E; Baghdasaryan A; Trauner M
Clin Liver Dis; 2013 May; 17(2):161-89. PubMed ID: 23540496
[TBL] [Abstract][Full Text] [Related]
6. Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders.
Fiorucci S; Zampella A; Distrutti E
Curr Top Med Chem; 2012; 12(6):605-24. PubMed ID: 22242859
[TBL] [Abstract][Full Text] [Related]
7. Pregnane X receptor as a therapeutic target for cholestatic liver injury.
Lan H; Zhang Y; Fan M; Wu B; Wang C
Drug Metab Rev; 2023 Nov; 55(4):371-387. PubMed ID: 37593784
[TBL] [Abstract][Full Text] [Related]
8. Xenobiotic-sensing nuclear receptors CAR and PXR as drug targets in cholestatic liver disease.
Kakizaki S; Takizawa D; Tojima H; Yamazaki Y; Mori M
Curr Drug Targets; 2009 Nov; 10(11):1156-1163. PubMed ID: 19925451
[TBL] [Abstract][Full Text] [Related]
9. Marine sponge steroids as nuclear receptor ligands.
Fiorucci S; Distrutti E; Bifulco G; D'Auria MV; Zampella A
Trends Pharmacol Sci; 2012 Nov; 33(11):591-601. PubMed ID: 23000093
[TBL] [Abstract][Full Text] [Related]
10. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
11. Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism.
Willson TM; Jones SA; Moore JT; Kliewer SA
Med Res Rev; 2001 Nov; 21(6):513-22. PubMed ID: 11607932
[TBL] [Abstract][Full Text] [Related]
12. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.
Molinaro A; Marschall HU
Biochem Soc Trans; 2022 Feb; 50(1):361-373. PubMed ID: 35191955
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
Zollner G; Trauner M
Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
[TBL] [Abstract][Full Text] [Related]
14. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
Cui YJ; Aleksunes LM; Tanaka Y; Goedken MJ; Klaassen CD
Toxicol Sci; 2009 Jul; 110(1):47-60. PubMed ID: 19407337
[TBL] [Abstract][Full Text] [Related]
15. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
[TBL] [Abstract][Full Text] [Related]
16. Pregnane X receptor is a target of farnesoid X receptor.
Jung D; Mangelsdorf DJ; Meyer UA
J Biol Chem; 2006 Jul; 281(28):19081-91. PubMed ID: 16682417
[TBL] [Abstract][Full Text] [Related]
17. FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
Panzitt K; Jungwirth E; Krones E; Lee JM; Pollheimer M; Thallinger GG; Kolb-Lenz D; Xiao R; Thorell A; Trauner M; Fickert P; Marschall HU; Moore DD; Wagner M
J Hepatol; 2020 Jun; 72(6):1122-1131. PubMed ID: 32001325
[TBL] [Abstract][Full Text] [Related]
18. Targeting FXR in cholestasis: hype or hope.
Fiorucci S; Distrutti E; Ricci P; Giuliano V; Donini A; Baldelli F
Expert Opin Ther Targets; 2014 Dec; 18(12):1449-59. PubMed ID: 25200104
[TBL] [Abstract][Full Text] [Related]
19. Role of farnesoid X receptor in cholestasis.
Yuan ZQ; Li KW
J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
[TBL] [Abstract][Full Text] [Related]
20. Lipid-activated transcription factors control bile acid glucuronidation.
Barbier O; Trottier J; Kaeding J; Caron P; Verreault M
Mol Cell Biochem; 2009 Jun; 326(1-2):3-8. PubMed ID: 19130183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
